The differentiation of megakaryocytes to platelets could be triggered by the tumor-associated inflammatory mediators, such as IL-1, IL-3, and IL-6 [70] that accelerate tumor cell growth and dissemination; in addition, platelets cooperate to protect circulating cancer cells from the immune system [71]. This evidence concerns the gene IL6 and neoplasm.